Prisys is a Shanghai-based nonhuman primate pharmacology CRO, pioneered NHP models covering a number of disease areas, including immunology (inflammation and autoimmunity), cardiovascula, cerebrovascula, hematology, hepatology, nephrology, pulmonology, OB-GYN, and oncology, to provide pharmacology studies for new medicines in nonclinical or preclinical phase, with human translatable endpoints.